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Abstract P fimbriae, enabling adherence to colonic and uri-
nary epithelium, and aerobactin, an iron sequestering system,
are both colonization factors in the human colon and virulence
factors for urinary tract infection. The colonic microbiota is
suggested to be a site suitable for the transfer of antibiotic
resistance genes. We investigated whether phenotypic resis-
tance to antibiotics in commensal and uropathogenic
Escherichia coli from infants and young children is associated
with carriage of virulence genes and to phylogenetic group
origin and, in the case of fecal strains, to persistence in the
gut and fecal population levels. The commensal strains
(n = 272) were derived from a birth cohort study, while the
urinary isolates (n = 205) were derived from outpatient clinics.
Each strain was assessed for phenotypic antibiotic resistance
and for carriage of virulence genes (fimA, papC, sfaD/E, hlyA,
iutA, kfiC, and neuB), phylogenetic group (A, B1, B2, or D),
and markers of particular virulent clones (CGA-D-ST69,
O15:H1-D-ST393, and O25b:H4-B2-ST131). Resistance to
ampicillin, tetracycline, and trimethoprim was most prevalent.
Multivariate analysis showed that resistance to any antibiotic
was significantly associated with carriage of genes encoding P
fimbriae (papC) and aerobactin (iutA), and a phylogenetic
group D origin. Neither fecal population numbers nor the
capacity for long-term persistence in the gut were related to
antibiotic resistance among fecal strains. Our study confirms
the importance of phylogenetic group D origin for antibiotic
resistance in E. coli and identifies the virulence genes papC
and iutA as determinants of antibiotic resistance. The reason
for the latter association is currently unclear.
Introduction
Escherichia coli is the leading cause of urinary tract infection
(UTI), which frequently occurs in infants and young children
[1]. Strains causing UTI usually originate in the patient’s own
colonic microbiota [2]. Escherichia coli strains segregate into
four major phylogenetic groups, termed A, B1, B2, and D.
Most strains causing UTI are found within group B2, and to
a lesser extent group D, while most strains belonging to the A
and B1 phylogenetic groups have low pathogenic potential
[3]. Further, a majority of uropathogenic E. coli strains express
P fimbriae, which mediates adherence to colonic and urinary
tract epithelium, the iron sequestering aerobactin system, and
certain O and K antigens. However, these traits are also asso-
ciated with superior capacity to colonize the human colon.
Thus, E. coli strains that persist for long periods in the com-
mensal microbiota more often than transient strains belong to
group B2 [4], have O and K antigens characteristic of
uropathogenic strains [5], and carry the genes for P fimbriae
and aerobactin [6, 7]. In a rodent model, P fimbriae and cap-
sule K5 confer the capacity to colonize the intestinal tract,
suggesting that known UTI virulence traits in E. coli might
primarily serve to increase fitness in the natural niche, the
colon [8, 9]. The colonic microbiota has been suggested to
be a milieu that favors transfer of antibiotic resistance genes
from resistant to initially susceptible strains, and fitness in the
human gut commensal microbiota might enhance the proba-
bility of acquisition of resistance genes [10]. Furthermore,
colonization of the human gut would increase the likelihood
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of the strains being exposed to antibiotics used in human clin-
ical practice, which would tend to positively select for
antibiotic-resistant strains in the microbiota.
Certain uropathogenic E. coli clones are known to have
accumulated antibiotic resistance genes, for example, clone
O25b:H4-B2-ST131 [11] that frequently carries genes
encoding extended-spectrum beta-lactamase (ESBL) of the
CTX-M-15 type [12], clone CGA-D-ST69 that is globally
spread and often carries genes conferring resistance to ampi-
cillin, chloramphenicol, streptomycin, sulfonamides, tetracy-
cline, and trimethoprim [13, 14], and clone O15:H1-D-ST393
that has acquired various antibiotic resistance genes over the
last several decades [15]. The prevalence of these clones
among commensal E. coli is unknown.
The aim of the present study was to investigate whether
resistance to commonly used antibiotics is related to phyloge-
netic group, markers of virulence, and fitness in the commen-
sal gut microbiota. Fecal and urinary E. coli isolates from
Swedish infants were screened for antibiotic resistance and
their virulence gene carriage, clonal origin, and phylogenetic
group allocation were analyzed. Uropathogenic clones with
known accumulation of antibiotic resistance genes were iden-
tified. A part of the fecal strains had previously been charac-
terized regarding fecal population counts and capacity for
long-term persistence in the microbiota [6]. Our results indi-
cate that certain virulence traits are associated with an
antibiotic-resistant phenotype.
Materials and methods
Commensal fecal E. coli strains from Swedish infants
In total, 272 commensal fecal E. coli strains isolated during
1998–2002 from 128 Swedish 0–1-year-old infants included
in the birth cohort ALLERGYFLORA were studied.
ALLERGYFLORA was designed to investigate the impact
of gut microbiota on allergy development and the methodol-
ogy has been described previously [16]. In brief, rectal swabs
obtained on day 3 were cultured semi-quantitatively and fecal
samples obtained at 1, 2, 4, and 8 weeks and at 6 and
12 months of age were cultured quantitatively on Drigalski
agar [16]. Isolates were speciated using the API 20E biotyping
system (bioMérieux, Marcy-l’Etoile, France) and E. coli were
strain-typed using random amplified polymorphic DNA and
analyzed regarding virulence gene carriage and phylogenetic
group allocation [4, 6]. In each fecal sample, the counts of
each strain [colony-forming units (CFU)/g feces] was deter-
mined [16]. In addition, for 70 of the 128 infants, each strain
has previously been characterized as resident or transient in
the microbiota of the infant, the former defined as colonizing
for at least 3 weeks, the latter for a shorter period [17], and the
E. coli colonization pattern of these 70 infants has been re-
ported [6].
Each of the 272 strains identified were included only once
in each analysis, even if it was isolated from an infant on
several sampling occasions.
Urinary E. coli isolates from Swedish infants
A total of 205 community-acquired urinary E. coli isolates
from 0–2-year-old children sampled in November 2002–
February 2003 or March 2004–August 2005 were included.
Consecutive urinary samples cultured at the Clinical
Microbiology Laboratory, Sahlgrenska University Hospital
and yielding E. coli as the primary pathogen were included
providing that: (1) they were derived from pediatric outpa-
tients’ clinics or the emergency ward at the Queen Silvia
Children’s Hospital in Gothenburg or (2) were from children
aged 0–2 years old who had not yielded a previous positive
urinary culture or been hospitalized prior to the positive sam-
ple. Isolation and speciation of E. coliwere done using routine
methods. For this study, each speciation was confirmed by
using API 20E biotyping (bioMérieux).
Virulence genotyping, phylogenetic group typing,
and clonal identification
All urinary isolates and 129 fecal E. coli strains that had pre-
viously not been analyzed were screened for carriage of fimA,
papC, sfaD/E, neuB, kfiC, iutA, and hlyA, as previously de-
scribed [6].
Assignment to one of the phylogenetic groups A, B1, B2,
or D was done using a previously described triplex polymer-
ase chain reaction (PCR) method [18].
All phylogenetic group D strains were screened for the
clones CGA-D-ST69 and O15:H1-D-ST393 [19–21].
Phylogenetic group B2 strains were screened to identify the
O25b:H4-B2-ST131 clone [22]. The E. coli strains CCUG
55212, CCUG 41424, and CCUG 61908 were used as refer-
ence strains.
Antibiotic susceptibility
Phenotypic resistance to antibiotics was assessed using the
agar disk diffusion method as described by the Nordic
Committee on Antimicrobial Susceptibility Testing
(NordicAST; http://www.nordicast.org). The following
antibiotic disks were used: ampicillin, cefuroxime, cefoxitin,
mecillinam, cefadroxil, ceftazidime, chloramphenicol,
gentamicin, tobramycin, nitrofurantoin, nalidixic acid,
tetracycline, and trimethoprim (Oxoid Ltd., Hants, UK).
Strains belonging to the CGA-D-ST69 clone were also tested
using disks containing streptomycin and sulfonamide. The
antibiotic disks were applied on agar plates seeded with
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bacteria and the plates were incubated aerobically at 37 °C for
16–24 h. Thereafter, the zone diameters were measured and
the strains were defined as sensitive or resistant according to
the breakpoints provided by NordicAST.
At least the first isolate of each strain (n = 272) was tested
for phenotypic resistance to antibiotics, and the resistance pat-
tern of the first isolate of each strain was used in the analyses.
Statistical methods
Proportions were compared using Fisher’s exact test
(GraphPad Prism; GraphPad Software, La Jolla, CA, USA).
The data were analyzed by multiple linear regression (SPSS
version 21 for Windows; SPSS Inc., Chicago, IL, USA) to
assess the independent association of different factors with
antibiotic resistance in E. coli.
Results
Antibiotic resistance in fecal and urinary E. coli strains
Twenty-one percent of the commensal fecal strains and 40%
of the urinary strains were resistant to at least one antibiotic
(p < 0.0001). Resistance against ampicillin, tetracycline, and
trimethoprim were most prevalent and more common among
UTI than fecal strains (p ≤ 0.002, Table 1).
Urinary strains were isolated somewhat later (2002–2005)
than the fecal strains (1998–2002). However, resistance rates
in neither of these strain collections increased over the sam-
pling period (data not shown). Furthermore, urinary strains
isolated in 2002 (n = 63) were significantly more resistant than
fecal strains collected during this year (n = 20) (p = 0.007).
Another potential source of confounding was that commensal
strains were isolated from 0–1-year-old infants, while urinary
strains derived from 0–2-year-old infants. However, when
comparing commensal strains isolated from 0–1-year-old in-
fants with UTI isolates from infants of the same age, resistance
was significantly higher in UTI isolates than commensal
strains, 21 vs. 42%, p < 0.0001. Further, resistance among
UTI isolates was not significantly different between isolates
from 0–1-year-old infants compared with those from 1–2-
year-old infants, 42 vs. 31%, p = 0.26.
Antibiotic resistance and phylogenetic lineages
Uropathogenic E. coli strains mostly belong to phylogenetic
groups B2 or D. Accordingly, a larger fraction of urinary com-
pared to fecal strains belonged to phylogenetic groups B2 (72
vs. 46%, p < 0.0001) and D (20 vs. 14%, p = 0.11). Instead,
more fecal than urinary strains belonged to phylogenetic
groups A (28 vs. 4%, p < 0.0001) and B1 (12 vs. 4%,
p = 0.002).
Resistance was more common among urinary than among
fecal strains within each phylogenetic group, the difference
being highly significant for groups B2 and D strains
(p = 0.009 and p = 0.003, respectively) and of borderline sig-
nificance for groups B1 and A strains (p = 0.05 for both).
Furthermore, regardless of clinical origin, group D strains
were significantly more often resistant than groups B2 and
B1 strains (urinary strains: p < 0.0001, p = 0.04; fecal strains:
p = 0.03, p = 0.004) (Fig. 1a).
Table 1 Prevalence of resistance
to antibiotics among fecal and
urinary Escherichia coli strains
deriving from Swedish infants
Resistance prevalence
Fecal strains (n = 272) Urinary isolates (n = 205) p-Value
n % n %
Ampicillin 32 12 60 29 <0.0001
Tetracycline 28 10 42 20 0.002
Trimethoprim 21 8 38 19 0.0006
Chloramphenicol 3 1 17 8 0.0001
Nalidixic acid 2 1 6 3 0.08
Nitrofurantoin 1 0.5 0 0
Gentamicin 0 0 2 1
Mecillinam 0 0 1 0.5
Any of the above antibiotics 57 21 82 40 <0.0001
Fecal E. coli strains derived from 128 infants followed during the first year of life with regular fecal sampling.
Individual strains were identified by random amplified polymorphic DNA [6]. UTI E. coli isolates were consec-
utive isolates obtained from positive urinary samples of children below 2 years of age presenting with UTI at
pediatric outpatient clinics or the emergency ward at the regional children’s hospital. All isolates were tested by
disk diffusion for resistance to the following antibiotics: ampicillin, cefuroxime, cefoxitin, mecillinam, cefadroxil,
ceftazidime, chloramphenicol, gentamicin, tobramycin, nitrofurantoin, nalidixic acid, tetracycline, and trimetho-
prim. Only p-values below 0.10 are presented (Fisher’s exact test)
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Figure 1b shows resistance to individual antibiotics in re-
lation to phylogenetic group origin. Urinary group D strains
were most often resistant to each of the antibiotics (p ≤ 0.0001
for each, compared to urinary strains of the other groups com-
bined) and fecal group D strains were more often resistant to
ampicillin than fecal strains of the other phylogenetic groups
(26 vs. 9%, p = 0.004).
As evident from Fig. 1b, ampicillin resistance was the most
common resistance type in groups B2 and D strains, regard-
less of origin, while groups A and B1 strains were more often
resistant to tetracycline than the other two antibiotics. Hence,
resistance to ampicillin was significantly more common in
strains belonging to groups B2 and D (combined) than in
strains belonging to groups A and B1 (combined), 23 vs.
11%, p = 0.001. In contrast, resistance to tetracycline was
equally common in strains from phylogenetic groups A and
B1 (combined) and from phylogenetic groups B2 and D
(combined) (15 vs. 17%, NS).
Antibiotic resistance and virulence factor genes
UTI strains more often than fecal strains carried all tested
virulence genes, i.e., fimA (74 vs. 73%, p = 0.92), papC (72
vs. 29%, p < 0.0001), sfaD/E (45 vs. 27%, p < 0.0001), hlyA
(45 vs. 22%, p < 0.0001), iutA (56 vs. 28%, p < 0.0001), neuB
(31 vs. 22%, p = 0.03), and kfiC (15 vs. 7%, p = 0.009).
Furthermore, the two virulence factors papC and iutA were
both significantly more common among UTI strains as com-
pared with fecal strains within the same phylogenetic group
(papC: p < 0.0001, iutA: p = 0.007 in group B2 strains; papC:
p = 0.0009, iutA: p < 0.0001 in group D strains).
The relation between antibiotic resistance and virulence gene
carriage is shown in Fig. 2. In both fecal (Fig. 2a) and UTI
strains (Fig. 2b), strains carrying papC or iutAwere more often
resistant to at least one of the tested antibiotics than were strains
lacking these traits. Figure 2c–f shows the association between
antibiotic resistance and virulence gene carriage within each
phylogenetic group, including both fecal and urinary strains in
the analyses. Carriage of papCwas significantly more common
among resistant than susceptible strains within phylogenetic
groups A (Fig. 2c), B2 (Fig. 2e), and D (Fig. 2f). Further,
carriage of the aerobactin gene, iutA, was significantly more
common in resistant than susceptible strains within the A, B1,
and D phylogenetic groups (Fig. 2c, d, f).
Prevalence of the CGA-D-ST69, O15:H1-D-ST393,
and O25b:H4-B2-ST131 clones
Among urinary E. coli, 24 strains (12%) belonged to the
CGA-D-ST69 clone, of which more than 75% carried iutA
and papC. Among the fecal strains, 3 (1%) belonged to this
clone, two of which carried fimA, papC, and iutA, and the third
one only fimA. Fifty percent of the urinary CGA-D-ST69 iso-
lates were resistant to at least three antibiotics, i.e., ampicillin
(58%), tetracycline (58%), and trimethoprim (54%). Among
the fecal CGA-D-ST69 strains, two were resistant to ampicil-
lin and trimethoprim, and one was susceptible to all the anti-
biotics tested. Resistance to at least one of the screened anti-
biotics was significantly more common among urinary CGA-
D-ST69 strains than among other urinary strains (75 vs. 35%,
p = 0.0003). As this clone is known to be resistant to sulfon-
amide and streptomycin, we tested resistance to these antibi-
otics and found 63 and 38% to be resistant, respectively [14].
Only one (0.5%) of the urinary strains and two (1%) of the
fecal strains belonged to the O15:H1-D-ST393 clone. All car-
ried the iutA gene, and two carried papC. Two of three strains
were each resistant to nalidixic acid and tetracycline, and the
third fecal strain acquired a resistance plasmid during its col-
onization in an infant’s gut, as described elsewhere [10].
The O25b:H4-B2-ST131 clone that belongs to phylogenet-
ic group B2was represented by two urinary strains (1.0%) and
Fig. 1 Antibiotic resistance in relation to phylogenetic group origin. a
Prevalence of resistance to any of the screened antibiotics among fecal
(Fae) and urinary (UTI) isolates as a function of phylogenetic group. b
Resistance to ampicillin (white bars), tetracycline (black bars), and
trimethoprim (checkered bars) as a function of phylogenetic group and
clinical origin. The asterisks denote significance comparing the resistance
of group D fecal or urinary strains to the other phylogenetic groups
combined (Fisher’s exact test)
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one fecal (0.4%) strain. All three carried iutA but were fully
susceptible to all the antibiotics tested.
Multiple regression analysis
As seen in Table 2, phylogenetic group D origin was a strong
independent predictor of being resistant to any of the screened
antibiotics, as well as for resistance to ampicillin or trimetho-
prim. Carriage of papC and iutA were also strong predictors
for resistance to any antibiotic, papC was also an independent
predictor for resistance to ampicillin, and iutAwas an indepen-
dent predictor for resistance to both ampicillin and tetracy-
cline. UTI origin was not an independent explanatory factor
for antibiotic resistance. CGA-D-ST69 clonal origin was sig-
nificantly associated with resistance to tetracycline (p = 0.03)
and tended to be associated with trimethoprim resistance
(p = 0.07, Table 2).
Relation of resistance to population levels and time
of persistence of E. coli strains in the microbiota
Figure 3 shows the population levels at different time points
after birth of strains that were resistant to at least one antibiotic
and fully susceptible strains. At each time point, population
counts for all strains that were isolated for the first time at that
particular time point were included in the analysis (Fig. 3).
There were no significant differences in population levels be-
tween resistant and fully susceptible strains on any sampling
occasion. Because of the low number of strains resistant to
ampicillin, tetracycline, or trimethoprim at each individual
time point, the comparison to susceptible strains was not per-
formed for strains resistant to individual antibiotics.
A part of the fecal strains had previously been characterized
with respect to their period of colonization in the commensal























Fig. 2 Antibiotic resistance in
relation to virulence gene
carriage. The prevalence (% of
isolates) of resistance to at least
one of the screened antibiotics is
shown in isolates with (black
bars) or without (white bars)
seven virulence genes among
fecal (a) and urinary (b) E. coli
strains or in strains belonging to
the four phylogenetic groups (c–
f); in this case, both urinary and
fecal strains were included.
*p < 0.05, **p < 0.01, and
***p < 0.001 (Fisher’s exact test)
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group B2 [4] and carry the papC and iutA operons [6, 7]. We
included these factors, as well as a phylogenetic group D origin,
as explanatory factors in a multiple regression analysis, to deter-
mine their contribution to antibiotic resistance. As shown in
Table 3, being resident in the microbiota did not contribute to
being resistant among the examined fecal strains. Belonging to
group B2 was a significant negative predictor of antibiotic resis-
tance, while papCwas a significant positive predictor (Table 3).
Discussion
In the present study, we investigated determinants of resis-
tance to commonly used antibiotics in fecal and urinary
E. coli strains from Swedish infants and young children below
2 years of age, and examined the relation between antibiotic
resistance, virulence gene carriage, and phylogenetic group
origin of the strains. In addition, we screened the strains to
identify three known uropathogenic clones, i.e., CGA-D-
ST69, O15:H1-D-ST393, and O25b:H4-B2-ST131, to deter-
mine if these clones contributed to the pool of antibiotic-
resistant E. coli colonizing and infecting Swedish infants. In
the multivariate analysis, we found three factors that contrib-
uted independently to the strains being resistant to at least one
Table 2 Multiple regression
analysis examining phylogenetic
group, clinical origin, and
virulence as determinants of





Any antibiotica Ampicillin Tetracycline Trimethoprim
Bb p-Valuec Bb p-Valuec Bb p-Valuec Bb p-Valuec
Interceptd −1.53 −0.77 −0.30 −0.33
Group D 1.02 0.002 1.04 0.004 0.36 0.39 0.90 0.03
papC 0.87 0.0001 0.78 0.006 0.47 0.88 0.36 0.29
iutA 0.74 0.001 0.63 0.02 0.98 0.001 0.62 0.06
UTI origin 0.30 0.23 0.57 0.05 0.34 0.28 0.45 0.19
CGA-D-ST69 0.66 0.23 0.48 0.36 1.23 0.03 1.01 0.07
a Resistance to the following antibiotics were included in the screening: ampicillin, cefuroxime, cefoxitin,
mecillinam, cefadroxil, ceftazidime, chloramphenicol, gentamicin, tobramycin, nitrofurantoin, nalidixic acid,
tetracycline, and trimethoprim
bB: standardized regression coefficient
c Bold p-value ≥ 0.05, statistically significant association
d Intercept: the point at which the curve intersects the y-axis



































Fig. 3 Fecal population counts of resistant and fully susceptible E. coli
strains in infants’ samples. Strains exhibiting resistance to at least one
antibiotic (filled circles) or strains susceptible to all screened antibiotics
(open circles) derived from infants followed with quantitative stool
cultures from 1 week to 1 year of age. The average counts of all
resistant and susceptible strains that were isolated for the first time at
each time point are presented. The numbers within parentheses denote
the number of strains represented on each sampling occasion
Table 3 Multiple regression analysis examining the role of
phylogenetic groups, virulence genes, and capacity to persist in the
microbiota as determinants of antibiotic resistance among fecal




Phylogenetic group D 0.5 0.42
Phylogenetic group B2 −1.3 0.04
papC 0.65 0.04
iutA 0.71 0.12
Resident strainse −0.20 0.74
a Resistance to any of the antibiotics listed in Tables 1 and 2 was the
dependent variable
b B: standardized regression coefficient
c Bold p-value ≥ 0.05, statistically significant association
d Intercept: the point at which the curve intersects the y-axis
e Ninety-five resident and 22 transient fecal E. coli strains were included
in the analysis. Resident strains were those isolated repeatedly from an
infant over a period of at least 3 weeks, while transient strains colonized
for less than 3 weeks
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of the screened antibiotics; belonging to phylogenetic group
D, and carrying the two UTI virulence genes, papC encoding
P fimbriae and iutA encoding aerobactin. Neither persistence
in the microbiota nor attaining high fecal population counts
were associated with antibiotic resistance among the fecal
strains.
Among the tested antibiotics, resistance to ampicillin, tet-
racycline, or trimethoprim were most common, but the prev-
alence was moderate compared to the reported figures from
many other countries during the same period [23, 24]. This is
in agreement with a generally low resistance rate among
Swedish clinical isolates observed in surveillance studies
(http://www.ecdc.europa.eu). Still, the 21% resistance rate
among fecal commensal strains found here is considerably
higher than the 14% reported in a Swedish study from the
1970s [25].
Resistance to tested antibiotics was significantly more
common among urinary than among fecal strains. This is in
accordance with other studies, showing that the frequency of
resistance in commensal E. coli is lower but correlated to the
resistance rate in clinical isolates from the same area [26].
However, clinical origin as a factor associated with resistance
disappeared in the multivariate analysis, indicating that phy-
logenetic group origin and virulence profile were the primary
explanatory factors. It is well known that papC and iutA are
accumulated in uropathogenic strains.
One factor promoting antibiotic resistance development
would be a pronounced capacity to pick up resistance ele-
ments transferred horizontally. Phylogenetic group D origin
was a significant independent determinant of antibiotic resis-
tance, in agreement with previous studies showing that a
group D phylogenetic background per se facilitates acquisi-
tion of resistance genes [27, 28]. In accordance, we have re-
ported on a case of transfer of a resistance plasmid from one
group D strain to another in the intestinal microbiota of a
child, in relation to treatment with ampicillin, to which the
donor strain was resistant [10].
CGA-D-ST69 is a clone that often exhibits multiresistance
due to a large conjugative plasmid containing several resis-
tance genes [13]. The CGA-D-ST69 isolates were the most
resistant ones, although fecal CGA-D-ST69 isolates were less
resistant than urinary isolates of this clone. A CGA-D-ST69
clonal origin was an independent explanatory factor for resis-
tance to tetracycline and tended to be an explanatory factor for
resistance to trimethoprim. Notably, only 1% of the fecal
strains, but 12% of the urinary isolates, belonged to this clone.
Almost 50% of the infantile fecal E. coli strains examined
here belonged to phylogenetic group B2, a figure that we have
reported previously [4]. Escherichia coli group B2 strains are
the most pathogenic, but had overall low antibiotic resistance
both in the urinary isolate collection and among the fecal
strains. Indeed, a phylogenetic group B2 origin was a signif-
icant negative predictor of antibiotic resistance among fecal
strains in the present study. The fact that B2 strains are less
likely to carry resistance genes compared to group D strains
confirms observations from previous studies [29]. Group B2
strains may be less prone to acquiring plasmids than group D
strains. Accordingly, virulence genes in group B2 strains are
mostly carried on pathogenicity islands located in the chromo-
some, whereas group D strains often carry virulence genes,
e.g., iutA, on plasmids [29]. However, group B2 is highly
genetically diverse, comprising at least nine subgroups [30],
some of which may be better at incorporating horizontally
transferred genetic elements than others. One of the most path-
ogenic clones of phylogenetic group B2 is O25b:H4-B2-
ST131, which is enriched in virulence factor genes and, now-
adays, frequently carries resistance genes encoding, e.g.,
CTX-M, KPC, or NDM enzymes [31]. Co-selection of resis-
tance genes, e.g., CTX-M, and virulence genes in plasmids of
the IncFII group was suggested to be of importance for the
worldwide dissemination of this clone [32]. However, the
three strains of this clone identified in the present study were
sensitive to all the antibiotics tested. Our low isolation rate and
lack of resistance among ST131 isolates likely reflect a low
prevalence of this clone in Sweden before 2005, and an over-
all low resistance rate in E. coli. The prevalence of ESBL-
producing E. coli was only 0.2% among urine isolates in
2004 in Western Sweden and only 10% of these isolates
belonged to the ST131 clone [33].
Carriage of either of the virulence genes papC and iutA
were independent explanatory factors for antibiotic resistance,
including any resistance or resistance to ampicillin. iutAwas
also an explanatory factor for tetracycline resistance. The pap
operon encodes P fimbriae, which enables adherence to both
urinary and colonic epithelial cells and favors both persistence
in the gut microbiota and urinary tract virulence [6, 7].
Aerobactin production, encoded by the iutA operon, is also
linked to both urinary virulence [34] and persistence in the
commensal gut microbiota [7]. Long-term persistence in the
microbiota could enhance the chances of acquiring resistance
genes and high population counts could also favor gene trans-
fer. However, we could not demonstrate any independent con-
tribution of long-term persistence in the microbiota on antibi-
otic resistance, nor did we observe any relation between fecal
population counts and resistance.
Possibly, resistance genes and virulence genes occur to-
gether on transposons or plasmids and are, therefore, co-se-
lected. Carriage of the iutA gene has previously been associ-
ated with antibiotic resistance in E. coli of extraintestinal ori-
gin [34] and is also common among strains producing ESBLs
of the CTX-M types [35, 36]. In previous studies, we observed
positive associations between carriage of tet genes encoding
tetracycline resistance and the virulence genes papC and iutA,
as well as between carriage of beta-lactamase genes and papC
in commensal E. coli strains [37, 38]. In contrast, carriage of
pap and hly genes is inversely related to resistance against
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fluoroquinolones in E. coli, possibly relating to a partial loss
of genomic pathogenicity islands as a consequence of resis-
tance mutations in genes encoding topoisomerases II and IV
[39]. As few strains in our material were resistant to quino-
lones, this potential association could not be examined here.
In conclusion, we confirmed that strains belonging to phy-
logenetic group D have a special propensity to be resistant to
antibiotics and showed that carriage of the virulence genes
papC and iutAwere also linked to resistance. The reason for
the latter observation remains to be explained.
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